Skip to main content
. 2012 May 14;14(3):R115. doi: 10.1186/ar3841

Figure 1.

Figure 1

Clinical response and body mass index (BMI) in ankylosing spondylitis (AS) patients after 6 months of treatment with infliximab, according to the three WHO BMI categories. BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C-reactive protein; NSAIDs, nonsteroidal antiinflammatory drugs; VAS, visual analogue scale.